The CSTB gene helps protect cells, especially brain cells, by keeping enzymes that break down proteins under control. If the CSTB gene does not work properly, nerve cells can become more vulnerable, which may lead to an inherited epilepsy with muscle jerks, seizures, and worsening coordination over time. In medicine, this gene is important because harmful variants are a known cause of progressive myoclonic epilepsy type 1, also called Unverricht-Lundborg disease. It is mainly known in clinical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that give your cells instructions for building molecules or directing processes in the body. Some genes carry the directions for making proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when certain processes take place, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
CSTBGene function
What if the gene works
The CSTB gene helps control enzymes that break down proteins inside cells. By keeping this activity balanced, it supports normal cell protection and is especially important for healthy brain function.
Risk
What if the gene does not work
Variants in the CSTB gene can cause progressive myoclonic epilepsy, often starting in childhood or adolescence with brief muscle jerks and seizures. Milder and more severe variants may influence when symptoms begin and how much movement control is affected.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the CSTB gene, no treatment or management approach specific to this gene is currently established. The CSTB gene is being studied in laboratory models as a possible treatment target and disease marker in progressive myoclonic epilepsy, but this has not yet changed routine drug choices.
Conditions associated with CSTB
Gene function
What if the gene works
Your cells rely on the CSTB gene to help control certain protein cutting enzymes and keep everyday cell activity balanced. Its protein, called cystatin B, acts like a gentle brake on normal protein breakdown inside cells. Understanding how the CSTB gene works in the body helps explain how cells clean up old material while protecting important cell parts.
The CSTB gene makes cystatin B, which slows certain protein cutting enzymes inside cells. This helps keep normal protein breakdown under control during routine cell maintenance.
Some enzymes controlled by cystatin B work in lysosomes (the cell's recycling centers). Keeping their activity balanced helps cells clear worn out material in an orderly way.
By putting a brake on excess enzyme activity, the CSTB gene helps protect important cell parts from unnecessary protein breakdown. This supports steady daily function across many tissues.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CSTB gene often lower cystatin B levels or make the protein unstable, so it works less well. A common change is an expanded repeated DNA segment near the start of the CSTB gene, which reduces gene activity, while other variants can weaken the protein or stop production. This shows how variants in the CSTB gene affect protein function: milder changes may leave some activity, while more severe changes in both copies often link to earlier onset.
How variants are linked to conditions
Pathogenic variants in the CSTB gene cause Unverricht-Lundborg disease, also called progressive myoclonic epilepsy type 1. This inherited condition usually begins in childhood or the teen years with stimulus-sensitive muscle jerks and seizures, and some people also develop balance or coordination problems over time. In practice, variants in the CSTB gene linked to progressive myoclonic epilepsy are most often found when both copies are affected, which can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CSTB, risk is mainly shaped by genetics rather than lifestyle. A person usually develops the related condition only if they inherit harmful CSTB changes in both copies of the gene, so family history and having parents who are related by blood can increase the chance.
Inheritance of CSTB variants
For families asking how variants of the CSTB gene are inherited, the well-established pattern is autosomal recessive. This means a person usually develops CSTB-related progressive myoclonic epilepsy only when they inherit one altered copy of the gene from each parent. Parents who each carry one CSTB gene variant are often unaffected themselves, and with each pregnancy there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy. Sons and daughters are affected at similar rates.
What does my CSTB result mean for my family?
For CSTB, family implications are usually discussed in a recessive pattern. Brothers and sisters of someone with a disease-causing CSTB result may also have the condition or be carriers, and parents are usually carriers even if they have no symptoms. Other relatives, such as adult siblings or cousins planning children, may also want to learn whether the variant runs in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the CSTB gene, doctors use genetic testing for CSTB variants on a blood or saliva sample. A lab reads the gene’s DNA code and, when needed, checks for extra repeated DNA stretches, which are a common type of variant in this gene.
When should I consider getting a genetic test?
Genetic testing for the CSTB gene may be considered if someone has repeated muscle jerks, seizures, and worsening problems with balance or movement starting in late childhood or the teen years, or if this condition runs in the family. A confirmed CSTB change can help explain the cause and support family planning discussions.
A genetic result is only one part of your health story
Genetic results can give valuable insight, yet what they can tell you depends on the condition and on the type of variant. Over time, the way the body works is shaped by many influences, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and makes the most sense when viewed alongside other parts of care. In other situations, it may offer a clear answer. In areas such as medication response, genetic results can also help put a person’s experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, do less for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way someone responds to medication. It looks at links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can help support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the CSTB gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. For questions about side effects, drug interactions, or whether a medicine is right for you, talk with your doctor or pharmacist.
History
Throughout history, doctors described families with a form of inherited myoclonic epilepsy later known as Unverricht-Lundborg disease. In the 1990s, genetic studies traced this condition to the CSTB gene, helping explain a long-recognized clinical pattern. Initially understood only through visible traits, later recognized as tied to a specific gene, this discovery marked an important step for epilepsy genetics. Researchers then found that many affected families carried an expanded repeated segment near the CSTB gene rather than a simple spelling change in the gene itself. From these first observations, research expanded steadily. That work helped connect older clinical descriptions with modern genetic diagnosis and gave families a clearer name for the condition running through generations.